HEALTH

Validation of Gazalle HEMEXDx HB Variant Test for Sickle Cell Disease Screening by ICMR

By TEAM CIRCULAR EXPRESS • 08 Apr 2026
👁 3 views
• The Indian Council of Medical Research (ICMR) has validated the Gazalle HEMEXDx HB variant test for screening Sickle Cell Disease.
• The assay demonstrated 100% sensitivity and specificity in a sample size of 300.
• Validation was conducted at ICMR-NIIH Mumbai and ICMR-CRMCH Chandrapur.
• Laboratory staff must undergo training before use to avoid technical errors, and field-testing is mandatory for all validated assays.
purpose of issuance
Validation of electrophoresis-based assay for Sickle Cell Disease screening
Most Important Details
Gazalle HEMEXDx HB variant test validated with 100% sensitivity and specificity; training required for staff; field-testing mandatory
Name of Officer
Heena Tabassum
Designation
Scientist & PO
Department / Organisation
Indian Council of Medical Research (ICMR)
Share

Regards, Circular Express

You are viewing
Validation of Gazalle HEMEXDx HB Variant Test for Sickle Cell Disease Screening by ICMR

For Circular Express Members Only

Enter your registered 10-digit mobile number to view this circular.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *